Novozymes A/S (OTCMKTS:NVZMY) Sees Large Volume Increase – Should You Buy?

Novozymes A/S (OTCMKTS:NVZMY) saw strong trading volume on Friday . 641,172 shares were traded during trading, an increase of 713% from the previous session’s volume of 78,904 shares.The stock last traded at $59.4450 and had previously closed at $58.53.

Novozymes A/S Stock Up 1.2%

The company has a debt-to-equity ratio of 0.26, a current ratio of 1.61 and a quick ratio of 1.00. The firm’s 50-day moving average price is $62.80 and its 200 day moving average price is $62.64. The firm has a market capitalization of $27.73 billion, a price-to-earnings ratio of 42.29, a price-to-earnings-growth ratio of 1.07 and a beta of 1.10.

Novozymes A/S (OTCMKTS:NVZMY) last announced its earnings results on Wednesday, February 25th. The biotechnology company reported $0.35 EPS for the quarter, missing analysts’ consensus estimates of $0.79 by ($0.44). The company had revenue of $1.18 billion for the quarter, compared to analyst estimates of $1.22 billion. Novozymes A/S had a net margin of 13.96% and a return on equity of 6.38%. Sell-side analysts expect that Novozymes A/S will post 1.82 EPS for the current year.

Novozymes A/S Company Profile

Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.

The company’s product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).